Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients

Table 3 Lipid, lipoprotein and apolipoprotein profile from patients with celiac disease and control subjects

	Patients with celiac disease (n = 20)	Control subjects (n = 20)	P
TG (mg/dL)	81 (65-119)	78 (60-114)	ns
TC (mg/dL)	185 ± 37	194 ± 39	ns
VLDL-C (mg/dL)	18 ± 8	17 ± 7	ns
LDL-C (mg/dL)	139 (89-149)	107 (95-147)	ns
HDL-C (mg/dL)	45 ±15	57 ±17	< 0.05
Non-HDL-C (mg/dL)	153 (105-167)	137 (112-167)	ns
Apo A-I (mg/dL)	130 ± 31	155 ± 29	< 0.05
Apo B (mg/dL)	93.6 ± 23.8	83.5 ± 20.7	ns
TG/HDL-C	2.09 (1.13-2.98)	1.29 (1.06-1.93)	ns
TC/HDL-C	4.19 (3.11-5.00)	3.52 (2.84-4.08)	< 0.05
ApoB/apo A-I	0.75 ± 0.25	0.55 ± 0.16	< 0.01

TG: Triglycerides; TC: Total cholesterol; VLDL: Very low density lipoprotein; LDL: Low density lipoprotein; HDL: High density lipoprotein; apo: Apolipoprotein; ns: Non significant. Data are shown as mean ± SD or median (interquartile range) according to data distribution.